Literature DB >> 29655449

Diagnosis of Myasthenia Gravis.

Mamatha Pasnoor1, Mazen M Dimachkie2, Constantine Farmakidis2, Richard J Barohn2.   

Abstract

Myasthenia gravis (MG) diagnosis is primarily clinically based. By the end of the clinical evaluation, clinicians have a sense as to whether presenting symptoms and elicited signs are weakly or strongly supportive of MG. Diagnostic tests can reaffirm the clinicians' impression. Edrophonium testing is rarely used but helpful in cases of measurable ptosis. Decremental response on slow-frequency repetitive nerve stimulation has a modest diagnostic yield in ocular MG but is helpful in generalized MG cases. The most sensitive test is single-fiber electromyography. In this article, the authors review the diagnostic testing approach of practicing clinicians for suspected MG cases.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetylcholine receptor–binding autoantibodies; Agrin; Edrophonium test; Low-density lipoprotein receptor–related protein 4 (LRP4); Muscle-specific tyrosine kinase (MuSK); Myasthenia gravis; Repetitive nerve stimulation; Single-fiber electromyography

Mesh:

Substances:

Year:  2018        PMID: 29655449     DOI: 10.1016/j.ncl.2018.01.010

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  14 in total

1.  Electrodiagnostic Characteristics Suggestive of Muscle-Specific Kinase Myasthenia Gravis.

Authors:  Michael Skolka; Christopher J Lamb; Devon I Rubin; Christopher J Klein; Ruple S Laughlin
Journal:  Neurol Clin Pract       Date:  2022-06

2.  Pembrolizumab-induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer.

Authors:  Maki Todo; Gou Kaneko; Suguru Shirotake; Yuki Shimada; Shintaro Nakano; Takashi Okabe; Shiho Ishikawa; Masafumi Oyama; Koshiro Nishimoto
Journal:  IJU Case Rep       Date:  2019-10-30

Review 3.  Pediatric Paroxysmal Exercise-Induced Neurological Symptoms: Clinical Spectrum and Diagnostic Algorithm.

Authors:  Federica Rachele Danti; Federica Invernizzi; Isabella Moroni; Barbara Garavaglia; Nardo Nardocci; Giovanna Zorzi
Journal:  Front Neurol       Date:  2021-06-01       Impact factor: 4.003

Review 4.  The mitochondrial biogenesis signaling pathway is a potential therapeutic target for myasthenia gravis via energy metabolism (Review).

Authors:  Lingling Ke; Qing Li; Jingwei Song; Wei Jiao; Aidong Ji; Tongkai Chen; Huafeng Pan; Yafang Song
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

5.  Pembrolizumab-induced myasthenia gravis with myositis in a patient with lung cancer.

Authors:  Makoto Hibino; Kazunari Maeda; Shigeto Horiuchi; Minoru Fukuda; Tetsuri Kondo
Journal:  Respirol Case Rep       Date:  2018-08-07

Review 6.  Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.

Authors:  Inga Koneczny; Ruth Herbst
Journal:  Cells       Date:  2019-07-02       Impact factor: 6.600

7.  Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial.

Authors:  Mamatha Pasnoor; Andrew J Heim; Laura Herbelin; Jeffrey Statland; Mazen M Dimachkie; Mara Becker; Richard J Barohn
Journal:  Kans J Med       Date:  2020-02-26

8.  Cranial Nerve IX and X Weakness: An Unusual Initial Presentation of Myasthenia Gravis.

Authors:  Nikhita Balabbigari; Jaskaran Purewal; Nfn Sakul; Anam Purewal; Vijaya Kankanala; Tiziana Califano
Journal:  Am J Case Rep       Date:  2020-08-10

9.  Myasthenia Gravis as an Immune-Mediated Side Effect of Checkpoint Inhibitors.

Authors:  Caio T Heleno; Ala Mustafa; Nico A Gotera; Amy Tesar
Journal:  Cureus       Date:  2021-07-11

Review 10.  How to manage with telemedicine people with neuromuscular diseases?

Authors:  Fiore Manganelli; Luigi Lavorgna; Emanuele Spina; Francesca Trojsi; Stefano Tozza; Aniello Iovino; Rosa Iodice; Carla Passaniti; Gianmarco Abbadessa; Simona Bonavita; Letizia Leocani; Gioacchino Tedeschi
Journal:  Neurol Sci       Date:  2021-06-25       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.